188 related articles for article (PubMed ID: 34981975)
1. Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.
Hou R; Grimm LJ; Mazurowski MA; Marks JR; King LM; Maley CC; Lynch T; van Oirsouw M; Rogers K; Stone N; Wallis M; Teuwen J; Wesseling J; Hwang ES; Lo JY
Radiology; 2022 Apr; 303(1):54-62. PubMed ID: 34981975
[TBL] [Abstract][Full Text] [Related]
2. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
Lee SA; Lee Y; Ryu HS; Jang MJ; Moon WK; Moon HG; Lee SH
Radiology; 2022 Nov; 305(2):307-316. PubMed ID: 35787199
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
J Am Coll Radiol; 2018 Mar; 15(3 Pt B):527-534. PubMed ID: 29398498
[TBL] [Abstract][Full Text] [Related]
5. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
[No Abstract] [Full Text] [Related]
6. High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study.
Hsieh YC; Lo C; Lee YH; Chien N; Lu TP; Tsai LW; Wang MY; Kuo WH; Chang YC; Huang CS
World J Surg Oncol; 2023 Feb; 21(1):48. PubMed ID: 36804000
[TBL] [Abstract][Full Text] [Related]
7. Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance.
Selvakumaran V; Hou R; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Lu LX; Devalapalli A; Kim C; Soo MS; Hwang ES; Lo JY; Grimm LJ
Acad Radiol; 2020 Nov; 27(11):1580-1585. PubMed ID: 32001164
[TBL] [Abstract][Full Text] [Related]
8. Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
Woodard GA; Price ER
AJR Am J Roentgenol; 2019 Apr; 212(4):919-924. PubMed ID: 30714832
[TBL] [Abstract][Full Text] [Related]
9. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors.
Venkatesh SL; Oseni TO; Bahl M
Clin Imaging; 2021 May; 73():101-107. PubMed ID: 33360004
[TBL] [Abstract][Full Text] [Related]
11. Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ.
Wu H; Jiang Y; Tian H; Ye X; Cui C; Shi S; Chen M; Ding Z; Li S; Huang Z; Luo Y; Peng Q; Xu J; Dong F
Comput Methods Programs Biomed; 2024 Mar; 245():108039. PubMed ID: 38266556
[TBL] [Abstract][Full Text] [Related]
12. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
[TBL] [Abstract][Full Text] [Related]
13. Ultrafast MRI and T1 and T2 Radiomics for Predicting Invasive Components in Ductal Carcinoma in Situ Diagnosed With Percutaneous Needle Biopsy.
Kim MY; Yoen H; Ji H; Park SJ; Kim SM; Han W; Cho N
Korean J Radiol; 2023 Dec; 24(12):1190-1199. PubMed ID: 38016679
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics.
Hong M; Fan S; Yu Z; Gao C; Fang Z; Du L; Wang S; Chen X; Xu M; Zhou C
J Magn Reson Imaging; 2023 Aug; 58(2):454-463. PubMed ID: 36440711
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
Tanaka K; Masuda N; Hayashi N; Sagara Y; Hara F; Kadoya T; Matsui A; Miyazaki C; Shien T; Tokunaga E; Hayashi T; Niikura N; Maeda S; Komoike Y; Bando H; Kanbayashi C; Iwata H
Breast Cancer; 2021 Jul; 28(4):896-903. PubMed ID: 33599914
[TBL] [Abstract][Full Text] [Related]
16. Breast ductal carcinoma in situ with micro-invasion versus ductal carcinoma in situ: a comparative analysis of clinicopathological and mammographic findings.
Zhang M; Lin Q; Su XH; Cui CX; Bian TT; Wang CQ; Zhao J; Li LL; Ma JZ; Huang JL
Clin Radiol; 2021 Oct; 76(10):787.e1-787.e7. PubMed ID: 34052010
[TBL] [Abstract][Full Text] [Related]
17. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics.
Gajdos C; Tartter PI; Bleiweiss IJ; Hermann G; de Csepel J; Estabrook A; Rademaker AW
Ann Surg; 2002 Feb; 235(2):246-51. PubMed ID: 11807365
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
[TBL] [Abstract][Full Text] [Related]
20. Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ.
Grimm LJ; Ghate SV; Hwang ES; Soo MS
Acad Radiol; 2017 Nov; 24(11):1364-1371. PubMed ID: 28705686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
